Comerica Bank Lowers Holdings in Option Care Health, Inc. $OPCH

Comerica Bank decreased its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 84.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 92,594 shares of the company's stock after selling 495,886 shares during the quarter. Comerica Bank owned about 0.06% of Option Care Health worth $2,950,000 at the end of the most recent quarter.

A number of other large investors have also added to or reduced their stakes in the stock. Victory Capital Management Inc. lifted its position in shares of Option Care Health by 129.5% during the third quarter. Victory Capital Management Inc. now owns 383,605 shares of the company's stock worth $10,649,000 after purchasing an additional 216,489 shares during the last quarter. Geneva Capital Management LLC lifted its position in shares of Option Care Health by 27.6% during the third quarter. Geneva Capital Management LLC now owns 1,369,862 shares of the company's stock worth $38,027,000 after purchasing an additional 296,216 shares during the last quarter. Massachusetts Financial Services Co. MA lifted its position in shares of Option Care Health by 2.7% during the third quarter. Massachusetts Financial Services Co. MA now owns 1,244,321 shares of the company's stock worth $34,542,000 after purchasing an additional 33,019 shares during the last quarter. Game Creek Capital LP bought a new stake in shares of Option Care Health during the third quarter worth $1,527,000. Finally, Tredje AP fonden bought a new stake in shares of Option Care Health during the third quarter worth $1,018,000. Hedge funds and other institutional investors own 98.05% of the company's stock.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on OPCH shares. UBS Group decreased their target price on Option Care Health from $45.00 to $39.00 and set a "buy" rating for the company in a research report on Friday. Citigroup reiterated an "outperform" rating on shares of Option Care Health in a research report on Tuesday, January 13th. Jefferies Financial Group reiterated a "buy" rating and set a $37.00 target price on shares of Option Care Health in a research report on Tuesday, January 13th. Bank of America downgraded Option Care Health from a "buy" rating to a "neutral" rating and set a $22.00 target price for the company. in a research report on Friday. Finally, Deutsche Bank Aktiengesellschaft reiterated a "buy" rating and set a $26.00 target price on shares of Option Care Health in a research report on Friday. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, Option Care Health currently has an average rating of "Moderate Buy" and a consensus price target of $32.08.

Option Care Health Stock Up 5.5%

NASDAQ:OPCH opened at $21.14 on Tuesday. Option Care Health, Inc. has a 1-year low of $18.01 and a 1-year high of $36.80. The company has a 50-day moving average of $29.15 and a 200 day moving average of $30.74. The firm has a market cap of $3.32 billion, a PE ratio of 16.39, a price-to-earnings-growth ratio of 1.12 and a beta of 0.68. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.64 and a quick ratio of 1.07.

Option Care Health (NASDAQ:OPCH - Get Free Report) last released its quarterly earnings data on Thursday, April 30th. The company reported $0.40 earnings per share for the quarter, topping analysts' consensus estimates of $0.37 by $0.03. Option Care Health had a net margin of 3.64% and a return on equity of 18.17%. The company had revenue of $1.35 billion during the quarter, compared to analyst estimates of $1.39 billion. During the same period in the prior year, the firm earned $0.40 earnings per share. The firm's revenue for the quarter was up 1.3% compared to the same quarter last year. Option Care Health has set its FY 2026 guidance at 1.820-1.920 EPS. As a group, research analysts anticipate that Option Care Health, Inc. will post 1.69 EPS for the current fiscal year.

Insiders Place Their Bets

In other Option Care Health news, CEO John Charles Rademacher acquired 12,500 shares of the stock in a transaction that occurred on Monday, May 4th. The stock was bought at an average cost of $21.18 per share, with a total value of $264,750.00. Following the completion of the purchase, the chief executive officer directly owned 695,152 shares in the company, valued at $14,723,319.36. The trade was a 1.83% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.70% of the stock is currently owned by company insiders.

About Option Care Health

Option Care Health NASDAQ: OPCH is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry's most experienced home infusion businesses.

Want to see what other hedge funds are holding OPCH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Option Care Health, Inc. (NASDAQ:OPCH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.